Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousPeripheral Blood Stem Cell TransplantationHematologic NeoplasmsTransplantation ChimeraStem CellsGraft SurvivalGraft vs Leukemia EffectBone Marrow TransplantationTreatment OutcomeMyeloablative AgonistsTissue DonorsBusulfanRemission InductionVidarabineRecurrenceGraft vs Tumor EffectHistocompatibility TestingLymphocyte TransfusionImmunosuppressive AgentsLeukemia, Myeloid, AcuteMultiple MyelomaRetrospective StudiesLeukemiaHematopoietic Stem CellsSiblingsCord Blood Stem Cell TransplantationCytomegalovirus InfectionsCombined Modality TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLiver TransplantationMinor Histocompatibility AntigensSalvage TherapyLymphocyte DepletionDisease-Free SurvivalWhole-Body IrradiationSurvival AnalysisAntilymphocyte SerumMyelodysplastic SyndromesSurvival RateVirus ActivationNeoplasm, ResidualHistocompatibilityAntigens, CD34Precursor Cell Lymphoblastic Leukemia-LymphomaMelphalanChimerismTime FactorsHepatic Veno-Occlusive DiseaseMesenchymal Stem Cell TransplantationT-LymphocytesCyclophosphamideKidney TransplantationCytomegalovirusHematopoietic Stem Cell MobilizationAntineoplastic Combined Chemotherapy ProtocolsAcute DiseaseCell TransplantationFollow-Up StudiesPrimary MyelofibrosisAnemia, AplasticHLA AntigensEmbryonic Stem CellsHematologic DiseasesPrognosisLeukemia, Myeloid, Accelerated PhaseTransplantation ImmunologyImmunosuppressionAntibodies, NeoplasmRoseolovirus InfectionsCytarabineBenzamidesAdult Stem CellsImmunocompromised HostLymphoproliferative DisordersLeukemia, MyeloidAntineoplastic AgentsFusion Proteins, bcr-ablReceptors, Purinergic P2X5Hodgkin DiseasePyrimidinesNuclear FamilyGraft RejectionHeart TransplantationCyclosporineCD8-Positive T-LymphocytesGanciclovirGranulocyte Colony-Stimulating FactorInfectionLymphoma, Non-HodgkinLiving DonorsAntigens, CDImmunotherapy, AdoptivePiperazinesFatal OutcomeFlow Cytometry